Ginsenoside Re: Its chemistry, metabolism and pharmacokinetics

Chinese Medicine

Volumn 7, Issue , 2012, Pages

  Peng, Dacheng ^a   Wang, Huashan ^b   Qu, Chenling ^c   Xie, Laihua ^d   Wicks, Sheila M ^e,f   Xie, Jingtian ^a,g  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c HENAN UNIVERSITY OF TECHNOLOGY   (China)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e One of the City Colleges of Chicago   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g Medical College of Shangqiu   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 OXO GINSENOSIDE; AGLYCONE; DAMMARANE DERIVATIVE; DRUG METABOLITE; GINSENOSIDE; PROTOPANAXADIOL; PROTOPANAXATRIOL; UNCLASSIFIED DRUG;

ANIMAL MODEL; DEGLYCOSYLATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DEGRADATION; DRUG ELIMINATION; DRUG ISOLATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSFORMATION; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EVAPORATIVE LIGHT SCATTERING DETECTION; GASTROINTESTINAL TRACT; GINSENG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE MICROWAVE ASSISTED EXTRACTION; HUMAN; INTESTINE FLORA; NONHUMAN; OXIDATION; PANAX QUINQUEFOLIUS; PLANT LEAF; PLANT ROOT; REVIEW; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84862792292     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-7-2     Document Type: Review

References (61)

1. Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009, 7(3):293-302.
2. Peng DC, Chen WP, Xie JT. Antihyperglycemic effects of ginseng and possible mechanisms. Drugs of the future 2008, 33(6):507-514.
3. Hofseth LJ, Wargovich MJ. Inflammation, cancer, and targets of ginseng. J Nutr 2007, 137(1 Suppl):183S-185S.
4. Chevallier A. Encyclopedia of herbal medicine. 2000, New York: DK Publishing Inc.
5. Blumenthal M, Goldberg A, Brinckmann J. Ginseng root. 2000, Newton, MA: Integrative Medicine Communications.
6. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004, 343:1-19.
7. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004, 9(3):259-274.
8. Hu SY. A contribution to our knowledge of ginseng. Am J Chin Med 1977, 5(1):1-23.
9. Attele AS, Wu JA, Yuan CS. Multiple pharmacological effects of ginseng. Biochem Pharmacol 1999, 58:1685-1693.
10. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002, 51(6):1851-1858.
11. Lee TK, Johnke RM, Allison RR, O'Brien KF, Dobbs LJ. Radioprotective potential of ginseng. Mutagenesis 2005, 20(4):237-243.
12. Xie JT, Mehendale SR, Li X, Quigg R, Wang X, Wang CZ, Wu JA, Aung HH, Rue PA, Bell GI, Yuan CS. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 2005, 1740(3):319-325.
13. Wang H, Peng D, Xie J. Ginseng leaf-stem: bioactive constituents and pharmacological functions. Chin Med 2009, doi:10.1186/1749-8546-4-20.
14. Peng L, Sun S, Xie L-H, Wicks SM, Xie J-T. Ginsenoside Re: Pharmacological Effects on Cardiovascular System. Cardiovascular Therapeutics 2011,
15. Lee SJ, Sung JH, Moon CK, Lee BH. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett 1999, 144(1):39-43.
16. Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S, Wang CZ, Hsu CW, Becker LB, Yin JJ, et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006, 532(3):201-207.
17. Qi LW, Wang CZ, Yuan CS. American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol 2010, 80(7):947-954.
18. Shi YSC, Zheng B, Li Y, Wang Y. Simultaneous determination of nine ginsenosides in functional foods by high performance liquid chromatography with diode array detector detection. Food Chemistry 2010, 123:1322-1327.
19. Gillis CN. Panax ginseng pharmacology: a nitric oxide link?. Biochem Pharmacol 1997, 54(1):1-8.
20. Fuzzati N. Analysis methods of ginsenosides. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 812(1-2):119-133.
21. Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005, 26(2):143-149.
22. Xie JT, Wang CZ, Wang AB, Wu J, Basila D, Yuan CS. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng. Acta Pharmacol Sin 2005, 26(9):1104-1110.
23. Li X, Sun J, Wang G, Hao H, Liang Y, Zheng Y, Yan B, Sheng L. Simultaneous determination of panax notoginsenoside R1, ginsenoside Rg1, Rd, Re and Rb1 in rat plasma by HPLC/ESI/MS: platform for the pharmacokinetic evaluation of total panax notoginsenoside, a typical kind of multiple constituent traditional Chinese medicine. Biomed Chromatogr 2007, 21(7):735-746.
24. Ota T, Fujikawa-Yamamoto K, Zong ZP, Yamazaki M, Odashima S, Kitagawa I, Abe H, Arichi S. Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res 1987, 47:3863-3867.
25. Banthorpe DV. Terpenoids. Natural Products. In. Essex: Longman Scientific and Technical 1994, 331-339.
26. Kim YS, Kim DS, Kim SI. Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2. Intl J Biochem Cell Biol 1998, 30:327-338.
27. Joo KM, Lee JH, Jeon HY, Park CW, Hong DK, Jeong HJ, Lee SJ, Lee SY, Lim KM. Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method. J Pharm Biomed Anal 2010, 51(1):278-283.
28. Peng L, Sun S, Xie L-H, Wicks SM, Xie JT, Ginsenoside R. Pharmacological effects on cardiovascular system. Cardiovasc Therap 2011, doi:10.1111/j.1755-5922.2011.00271.x.
29. Xie JT, Aung HH, Wu JA, Attele AS, Yuan CS. Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am J Chin Med 2002, 30(2-3):187-194.
30. Xie JT, Mehendale SR, Wang A, Aung HH, Wu J, Osinski J, Yuan C-S. American ginseng leaf: Ginsenoside analysis and hypoglycemic activity. Pharmacol Res 2004, 49:113-117.
31. Li TSC, Mazza G, Cottrell AC, Gao L. Ginsenosides in roots and leaves of American ginseng. J Agric Food Chem 1996, 44:717-720.
32. Xie JT, Mehendale SR, Wang A, Han AH, Wu JA, Osinski J, Yuan CS. American ginseng leaf: ginsenoside analysis and hypoglycemic activity. Pharmacol Res 2004, 49(2):113-117.
33. Dharmananda S. The nature of ginseng: traditional use, modern research, and the question of dosage. Herbalgram 2002, 54:34-51.
34. Wang A, Wang CZ, Wu JA, Osinski J, Yuan CS. Determination of major ginsenosides in Panax quinquefolius (American ginseng) using high-performance liquid chromatography. Phytochem Anal 2005, 16(4):272-277.
35. Lim W, Mudge KW, Vermeylen F. Effects of population, age, and cultivation methods on ginsenoside content of wild American ginseng (Panax quinquefolium). J Agric Food Chem 2005, 53(22):8498-8505.
36. Shibata S, Tanaka O, Shoji J, Saito H. Chemistry and pharmacology of Panax. Economic and Medicinal plant Research 1985, 1:217-283.
37. Luchtefeld R, Kostoryz E, Smith RE. Determination of ginsenosides Rb1, Rc, and Re in different dosage forms of ginseng by negative ion electrospray liquid chromatography-mass spectrometry. J Agric Food Chem 2004, 52(16):4953-4956.
38. Xia C, Wang G, Sun J, Hao H, Xiong Y, Gu S, Shang L, Zheng C. Simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat plasma by liquid chromatography/electrospray ionization mass spectrometric method and its application to pharmacokinetic study of 'SHENMAI' injection. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 862(1-2):72-78.
39. Xie J-T, Attele AS, Yuan C-S. Ginseng: beneficial and potential adverse effect. A textbook of complementary and alternative therapies 2006, 71-89. Boca Raton, London, New York, Washington, D.C.: CRC Press Company, Yuan C-S, Beiber E, Bauer BA.
40. Kang SY, Schini-Kerth VB, Kim ND. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sciences 1995, 56(19):1577-1586.
41. Zhu GY, Li YW, Hau DK, Jiang ZH, Yu ZL, Fong WF. Protopanaxatriol-type ginsenosides from the root of Panax ginseng. J Agric Food Chem 2011, 59(1):200-205.
42. Mizuno M, Yamada J, Terai H, Kozukue N, Lee YS, Tsuchida H. Differences in immunomodulating effects between wild and cultured Panax ginseng. Biochem Biophys Res Commun 1994, 200(3):1672-1678.
43. Leung KW, Wong AS. Pharmacology of ginsenosides: a literature review. Chin Med 2010, 5:20.
44. Schlag EM, Mclntosh MS. Ginsenoside content and variation among and within American ginseng (Panax quinquefolius L.) populations. Phytochemistry 2006, 67:1510-1519.
45. Mihalov JJ, Marderosian AD, Pierce JC. DNA identification of commercial ginseng samples. J Agric Food Chem 2000, 48(8):3744-3752.
46. Qu C, Bai Y, Jin X, Wang Y, Zhang K, You J, Zhang H. Study on ginsenosides in different parts and ages of Panax quinquefolius L. Food Chemistry 2009, 115:340-346.
47. Wu JM, Lin HY, Zhao LH, Jia HT, Jia HK, Wang Y, Chen DW. Comparative study on quality of Tongrentang red ginseng and Korean red ginseng-determination of ginsenosides and polysaccharides. Zhongguo Zhong Yao Za Zhi 2007, 32(7):573-577.
48. Sritularak B, Morinaga O, Yuan CS, Shoyama Y, Tanaka H. Quantitative analysis of ginsenosides Rb1, Rg1, and Re in American ginseng berry and flower samples by ELISA using monoclonal antibodies. Nat Med (Tokyo) 2009, 63(3):360-363.
49. Morinaga O, Uto T, Yuan CS, Tanaka H, Shoyama Y. Evaluation of a new eastern blotting technique for the analysis of ginsenoside Re in American ginseng berry pulp extracts. Fitoterapia 2009, doi:10.1016/j.fitote.2009.10.005.
50. Lee M-J, Choi J-S, Cha S-W, Lee K-S, Lee Z-W, Hwang G-S, Lee SH, Kamal AHM, Jung Y-A, Seung N-S, Woo S-H. Variation in the ginsenoside profiles of cultivated ginseng (Panax ginseng C.A. Meyer) landraces in Korea. Process Biochemistry 2011, 46(1):258-264.
51. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004, 95(2):153-157.
52. Christensen L. Ginsenosides: Chemistry, Biosynthesis, Analysis, and Potential Health Effects. Advances in Food and Nutrition Research 2008, 55:1-99.
53. Li X, Wang G, Sun J, Hao H, Xiong Y, Yan B, Zheng Y, Sheng L. Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats. Biol Pharm Bull 2007, 30(5):847-851.
54. Qi L-W, Wang C-Z, Yuan C-S. Isolation and analysis if ginseng: advances and challenges. Nat Prod Rep 2011, DOI: 10.1039/c0np000057d.
55. Han BH, Park MH, Han YN, Woo LK, Sankawa U, Yahara S, Tanaka O. Degradation of Ginseng Saponins under Mild Acidic Conditions. Planta Med 1982, 44(3):146-149.
56. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Despos 2003, 31:1065-1071.
57. Bae EA, Shin JE, Kim DH. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol Pharm Bull 2005, 28(10):1903-1908.
58. Chi H, Ji GE. Transformation of Ginsenosides Rb1 and Re from Panax ginseng by Food Microorganisms. Biotechnol Lett 2005, 27(11):765-771.
59. Chen G, Yang M, Guo D. Metabolic study of ginsenoside Re in rats. Zhongguo Zhong Yao Za Zhi 2009, 34(12):1540-1543.
60. Yang L, Xu S, Liu C, Su Z. In vivo metabolism study of ginsenoside Re in rat using high-performance liquid chromatography coupled with tandem mass spectrometry. Anal Bioanal Chem 2009, 395:1441-1453.
61. Liu YM, Yang L, Zeng X, Deng YH, Feng Y, Liang WX. Pharmacokinetics of ginsenosides Rg1 and Re in Shenmai injection. Yao Xue Xue Bao 2005, 40(4):365-368.